Consort sniffs out new growth area with nasal drug delivery contract
This article was originally published in Clinica
Executive Summary
Consort Medical is diversifying out of its traditional inhaler and autoinjector markets with a new contract for its Bespak division to develop a nasal drug delivery device for an unnamed global pharmaceutical company. The device, which will be used for an undisclosed application, is expected to be launched in 2015.